These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7739273)

  • 21. Use of outpatient drugs as death approaches.
    Stuart B; Coulson NE
    Health Care Financ Rev; 1994; 15(3):63-82. PubMed ID: 10137798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usage of over-the-counter products by private insured patients in Germany - a claims data analysis with focus on complementary medicine.
    Goetz K; Kalder M; Albert US; Jacke CO
    BMC Health Serv Res; 2020 Jul; 20(1):651. PubMed ID: 32660646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC; Bohn RL; Avorn J
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research on choices of people with mild symptoms of common cold between consulting physicians and taking OTC (over-the-counter) medicine using a hypothetical question method].
    Sugawara T; Ohkusa Y; Kondo M; Honda Y; Okubo I
    Nihon Koshu Eisei Zasshi; 2005 Jul; 52(7):618-26. PubMed ID: 16130888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly?
    Francis SA; Barnett N; Denham M
    Drugs Aging; 2005; 22(5):361-70. PubMed ID: 15903349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C; Regan S; Henault LE; Hylek EM; Schwartz GR
    J Am Geriatr Soc; 2007 Jul; 55(7):1038-43. PubMed ID: 17608876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do seniors get the medicines prescribed for them? Evidence from the 1996-1999 Medicare Current Beneficiary Survey.
    Craig BM; Kreling DH; Mott DA
    Health Aff (Millwood); 2003; 22(3):175-82. PubMed ID: 12757282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives.
    Gür Ali O; Topaler B
    Eur J Health Econ; 2011 Dec; 12(6):553-62. PubMed ID: 20717700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Andrade SE; Gurwitz JH
    J Am Geriatr Soc; 2002 Jan; 50(1):178-81. PubMed ID: 12028265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender differences in drug use and expenditures in a privately insured population of older adults.
    Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
    J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic aspects of prescription drug use in an elderly population.
    Stuart B; Coulson NE
    Health Serv Res; 1993 Jun; 28(2):237-64. PubMed ID: 8514502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population.
    Sihvo S; Klaukka T; Martikainen J; Hemminki E
    Eur J Clin Pharmacol; 2000 Sep; 56(6-7):495-9. PubMed ID: 11049013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.
    Oster G; Huse DM; Delea TE; Colditz GA; Richter JM
    Med Care; 1990 Sep; 28(9):834-52. PubMed ID: 1976142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geography still dictates Rx coverage for many near-poor seniors and disabled persons.
    Miller EA; Weissert WG
    J Aging Soc Policy; 2007; 19(1):77-96. PubMed ID: 17347118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient prescription drug spending by the Medicare population.
    Waldo DR
    Health Care Financ Rev; 1987; 9(1):83-9. PubMed ID: 10312274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.